Jack is a first-year at the University of Chicago planning to major in Business Economics and Biology. He is interested in the economics of human health — specifically how shocks in biology (e.g. GLP-1 drugs) rewrite market structure, consumer demand, food systems, and corporate strategy. For Fershman, he is especially interested in writing about the future of obesity drugs, the incentives in the healthcare system, and how investors value treatments that depend on behavior change versus treatments that work at the molecular level.
